Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

16.06 -0.15 (-0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 531,202
Open 16.21
Bid (Size) 16.04 (800)
Ask (Size) 16.06 (700)
Prev. Close 16.21
Today's Range 16.00 - 16.25
52wk Range 9.100 - 21.03
Shares Outstanding 49,471,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-11.5%
-11.5%
1 Month
-4.2%
-4.2%
3 Month
-11.7%
-11.7%
6 Month
-20.9%
-20.9%
1 Year
+75.5%
+75.5%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
From Pomerantz LLP
Via GlobeNewswire
News headline image
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
News headline image
TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗
Via Stocktwits
Topics Workforce
Which stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alkami Stock Down 50%, But This New $49 Million Stake Signals Conviction in a Turnaround ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Integer Holdings Lands New $99 Million Stake Even With Stock Down Over 30% This Past Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Fund Builds $40 Million SPS Commerce Stake as Shares Sink 60% Despite 100 Straight Growth Quarters ↗
Via The Motley Fool
Topics Economy Regulatory Compliance Supply Chain
News headline image
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗
Via The Motley Fool
News headline image
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Irenic Dumps Most Papa John's Shares ↗
Via The Motley Fool
Topics ETFs Regulatory Compliance
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗
Via The Motley Fool
News headline image
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗
Via The Motley Fool

Frequently Asked Questions

Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?
Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.
What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?
Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?
The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market
What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?
The current price of Theravance Biopharma, Inc. - Ordinary Shares is 16.06
When was Theravance Biopharma, Inc. - Ordinary Shares last traded?
The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 05/29/26 04:00 PM ET
What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?
The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 794.50M
How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?
Theravance Biopharma, Inc. - Ordinary Shares has 795M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.